Iran's Shift Towards Chemical and Biological Weapons Amid Nuclear Setbacks
With nuclear ambitions curtailed, Iran is likely to enhance its chemical and biological weapons capabilities, focusing on ballistic warheads. The regime's existing arsenals and ongoing research suggest a significant shift in strategy towards these alternative weapons of mass destruction.
Theia Market Signal Identification - AI Assisted
Iran is expected to prioritize the development of chemical and biological weapons (CBW) in light of setbacks to its nuclear weapons program. The regime has a history of pursuing CBW capabilities while adhering to international conventions, with operational programs dating back to at least 2005.
Key facilities targeting CBW assets have been identified, including Malek-Ashtar University and Imam Hussein University, which suffered damage during recent conflicts. Iran's arsenal includes pharmaceutical-based agents and potentially Novichok nerve agents, synthesized at its defense laboratories.
The production of highly lethal agents, such as snake venoms and virulent viruses, is also ongoing. As barriers to ballistic missile development arise, Iran may adapt existing munitions for CBW payloads, potentially escalating regional tensions. The continuation of these programs poses significant risks for global security.
Comments